IDEX Biometrics ASA: Approved prospectus - 29 September 2025

29 Sep 2025 18:00 CEST

Reference is made to the Oslo Stock Exchange announcement issued by IDEX
Biometrics ASA' on 21 July 2025 of a private placement of 9,090,909 shares at
NOK 3.30 per share, split in two tranches.
The FSA has today approved the Prospectus.
By reason of the approval and publication of the Prospectus, the Shares (tranche
two and underwriting shares) will be transferred to the Company's ordinary ISIN
and be admitted to trading on Oslo Stock Exchange.

For further information, please contact:
Anders Storbråten, CEO and CFO
Tel: +47 416 38 582
E-mail: ir@idexbiometrics.com (mailto:ir@idexbiometrics.com)

About IDEX Biometrics:
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint
biometrics, offering authentication solutions across payments, access control,
and digital identity. Our solutions bring convenience, security, peace of mind
and seamless user experiences to the world. Built on patented and proprietary
sensor technologies, integrated circuit designs, and software, our biometric
solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market. For
more information, visit www.idexbiometrics.com (http://www.idexbiometrics.com)

About this notice:
This notice was issued by Kjell-Arne Besseberg, COO, on 29 September 2025 at
18:00 CEST on behalf of IDEX Biometrics ASA. This information is subject to the
disclosure requirements pursuant to the Norwegian Securities Trading Act section
5-12.

More information:
Access the news on Oslo Bors NewsWeb site

656374_2025-09 Prospectus - IDEX Biometrics ASA_final.pdf